The antitumor effects of CBD were shown to depend on TRPV1 in human neuroblastoma [44], cervical, lung, and breast cancer [39,40], and colon adenocarcinoma [36], but not in glioblastoma [12,13], human leukemia, or murine thymoma [31]. This evidence concerns the gene TRPV1 and breast carcinoma.